Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis

Clinical trial NCT06072001 · UNKNOWN

Trial details

NCT number: NCT06072001
Sponsor: Apurano Pharmaceuticals GmbH
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Pain Pain Syndrome Pain, Chronic Chronic Pain Chronic Pain Syndrome Neuropathic Pain Central Neuropathic Pain Paraplegia Multiple Sclerosis Stroke Phantom Limb Syndrome With Pain Phantom Pain

Start date: 2023-11-02
Primary completion: 2024-09-30
Enrollment: 558

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.